Z-0295-2021 Class II Terminated

Recalled by Becton Dickinson & Company — Franklin Lakes, NJ

FDA device recall Z-0295-2021 was initiated by Becton Dickinson & Company on Sep 14, 2020 and is designated Class II. Reason for recall: Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit. The recall status is terminated (terminated Nov 9, 2021). Affected quantity: 72 units.

Recall details

Product Type
Devices
Report Date
Nov 4, 2020
Initiation Date
Sep 14, 2020
Termination Date
Nov 9, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
72 units

Product description

Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208

Reason for recall

Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.

Distribution pattern

Foreign: Italy, Spain, and UK

Code information

Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0295-2021
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0295-2021. Report a data issue: hello@regdatalab.com.